Compare · head to head
Daewon Pharmaceutical vs Il Dong Pharmaceutical
Il Dong Pharmaceutical ranks higher overall — 360 rank 53 vs 46.
Daewon Pharmaceutical leads on Value (55 vs 46) and Sentiment (59 vs 39). Il Dong Pharmaceutical leads on Growth (62 vs 51) and Safety (47 vs 22). The two are close on Quality.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7003220001 | KR7249420001 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 46 | 53 |
| Value | 55 | 46 |
| Quality | 59 | 58 |
| Growth | 51 | 62 |
| Safety | 22 | 47 |
| Sentiment | 59 | 39 |
| Quality details | ||
| Profitability | 64 | 74 |
| Cash Truth | 53 | 42 |
Daewon Pharmaceutical vs Towa PharmaceuticalDaewon Pharmaceutical vs Reyon PharmaceuticalDaewon Pharmaceutical vs PharmGen ScienceDaewon Pharmaceutical vs Rohto PharmaceuticalAdd a third stock →
Full analyses: Daewon Pharmaceutical · Il Dong Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100